FDA Inspection
Washington Regional Transplant CommunityWashington Regional Transplant Community – FDA Inspection, Oct 13, 2022
Record Details
This FDA Inspection record concerns Washington Regional Transplant Community, with an inspection on October 13, 2022, issued by the Center for Biologics Evaluation and Research, covering biologics.
- Inspection Date
- October 13, 2022
- Product Type
- Biologics
View Company Profile
ID · 694c8ded-0414-4bc4-9c3a-6f00bf263e8b
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1181766
- FDA center
- Biologics
- Project area
- Vaccines and Allergenic Products
Other FDA inspections of Washington Regional Transplant Community
6| Date | Classification | Office | Project area |
|---|---|---|---|
| March 19, 2019 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| January 31, 2017 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| February 2, 2015 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| April 9, 2013 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
| April 19, 2011 | NAI | Center for Biologics Evaluation and Research | Human Cellular, Tissue, and Gene Therapies |
Other documents for Washington Regional Transplant Community
- FDA Inspection 1084996 - 2019-03-19
- FDA Inspection 1003957 - 2017-01-31
- FDA Inspection 912243 - 2015-02-02
- FDA Inspection 832609 - 2013-04-09
- FDA Inspection 730013 - 2011-04-19
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.